Recce Ltd has released a press release.
Appendix 4D and Half Yearly Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Recce Pharmaceuticals Ltd. on 6ix
Story so far
Earlier from Recce Pharmaceuticals
- Recce Applies for Dual Listing on Frankfurt Stock Exchange
- Fiona Stanley Hospital Phase I/II Clinical Trial Agreement
- Further Encouraging COVID Results at Doherty
- R&D Incentive Rebate Received
- Positive Intranasal Animal Data against SARS-CoV-2 in Study
Later from Recce Pharmaceuticals
- Recce Pharmaceuticals Dual Lists on Frankfurt Stock Exchange
- S&P DJI Announces March 2021 Quarterly Rebalance
- Anti-Viral Patent Granted in EU for RECCE Anti-Infectives
- Positive Sinusitis Data Against Infection
- Positive Sinusitis Patient Update - Special Access Scheme
Follow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals